Mindray Medical (MR) Tops Q3 EPS by 6c; Revs Light
More News related to MR
- Goldman Sachs Upgraded Mindray Medical (MR) to Conviction Buy
- Mindray to Hold Annual General Meeting in Hong Kong on December 15, 2009
- Mindray Medical to Exhibit at RSNA 2009 in Chicago, from November 29th to December 4th, 2009
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Mindray Medical (MR) Posts Q3 EPS of $0.38, Tops by 11c
More News related to Earnings
- Maxim Group Initiates Coverage on Golden Green Enterprises (CHOP) with a Buy
- Hilliard Lyons Initiates Coveage on Approach Resources (AREX) with a Buy
- Wells Fargo Transfers Coverage on Intuitive Surgical (ISRG) to a Market Perform; Raises Valuation Range
- Wedbush Initiates Coverage on Coinstar (CSTR) with an Outperform
- Thomas Weisel Starts FARO Tech. (FARO) at Overweight, $24 Price Target
Mindray Medical International Limited (NYSE: MR) reports Q3 EPS of $0.33, 6 cents better than estimates. Revenues were $151.1 million vs. $154.98 million consensus.
[SM]
Related Categories
EarningsStocks Mentioned
+0.54Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
